Letter: the efficacy and safety of rifaximin for the prophylaxis of spontaneous bacterial peritonitis in cirrhotic patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|5|697-698

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.5, 2018-03, pp. : 697-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 123-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 123-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: nutritional benefits of rifaximin in cirrhotic patients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 699-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis‐associated septic shock: a retrospective cohort study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 747-757

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2121-2128

John Wiley & Sons Inc

Access to resources Recommend Favorite